# OnCo record bnt324 (drug). Data CC BY-NC 4.0, attribute "Data from OnCo (onco.cc)". Whole corpus: https://onco.cc/api/v1/onco.nt
@prefix schema: <https://schema.org/> .
@prefix onco: <https://onco.cc/ns#> .
@prefix xsd: <http://www.w3.org/2001/XMLSchema#> .

<https://onco.cc/drugs/bnt324/>
  a schema:Drug ;
  onco:kind "drug" ;
  schema:identifier "bnt324" ;
  schema:name "BNT324"@en ;
  schema:description "BNT324 is an experimental antibody-drug conjugate from BioNTech SE in phase 3 trials for prostate cancer and non-small-cell lung cancer, aimed at B7-H3."@en ;
  schema:url <https://onco.cc/drugs/bnt324/> ;
  schema:dateModified "2026-09-11"^^xsd:date ;
  schema:citation <https://clinicaltrials.gov/search?intr=DB-1311> ;
  onco:status "phase-3" ;
  onco:tag "pipeline", "ctgov-ingest" ;
  onco:modality "ADC" ;
  onco:cancers <https://onco.cc/cancers/prostate/>, <https://onco.cc/cancers/nsclc/> ;
  onco:targets <https://onco.cc/targets/b7h3/> ;
  onco:companies <https://onco.cc/companies/biontech/> ;
  onco:trials <https://onco.cc/trials/nct07365995/>, <https://onco.cc/trials/nct05914116/>, <https://onco.cc/trials/nct06892548/>, <https://onco.cc/trials/nct06953089/> .